查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1540845

2024-2032 年按藥物類別、給藥途徑、配銷通路、應用和地區分類的抗凝血劑市場報告

Anticoagulants Market Report by Drug Class, Route of Administration, Distribution Channel, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年全球抗凝血劑IMARC Group規模達412億美元。血栓性疾病病例的增加、久坐的生活方式以及醫療保健產業的改善是推動市場發展的一些關鍵因素。

抗凝血劑是防止血栓形成並減少中風和心臟病等嚴重疾病的機會的藥物。它們有助於治療現有的阻礙血管流動的血栓，防止血栓變大，並降低嚴重併發症的風險。它們有不同的規格和顏色，有口服劑型（如片劑和膠囊）和注射劑型。目前，由於直介面服抗凝血劑（DOAc）易於使用且無需常規監測，越來越多的人開始使用直介面服抗凝血劑。

抗凝血劑市場趨勢：

全球老年人口不斷成長，人類免疫缺陷病毒（HIV）、萊姆病、肥胖、C型肝炎、慢性發炎和心血管疾病的盛行率不斷上升，是對全球市場產生積極影響的關鍵因素之一。此外，由於久坐的生活方式和忙碌的工作安排，導致肺栓塞（PE）等血栓性疾病病例不斷增加，導致全球心臟相關疾病的增加。此外，久坐、吸菸、外傷、血液疾病和自體免疫疾病正在增加身體不同部位血液凝固的風險，這反過來又促進了對抗凝劑的需求。除此之外，藥物發現的研發（R＆D）活動不斷進步，以及人工智慧（AI）和機器學習（ML）等先進技術的整合，以分析大量資料，識別潛在的候選藥物並開發一種新藥正在推動市場成長。據此，醫療保健提供者正在專注於根據個別患者的遺傳和臨床資料進行個人化抗凝血治療。人工智慧有助於確定患者最有效的抗凝血劑劑量和類型，從而降低併發症風險並改善預後。此外，非營利組織為提高心血管健康意識而採取的有利舉措，以及各國政府和公共衛生機構之間為預防心臟病和中風而不斷加強的合作夥伴關係，正在推動全球市場的成長。其他因素，如蓬勃發展的醫療保健行業以及藥品的可負擔性和可及性的提高，正在刺激市場的成長。

本報告回答的關鍵問題

  • 2023年全球抗凝血劑市場規模有多大？ 2024-2032年全球抗凝血劑市場的預期成長率是多少？
  • 推動全球抗凝血劑市場的關鍵因素是什麼？
  • COVID-19 對全球抗凝血劑市場有何影響？
  • 根據藥物類別，全球抗凝血劑市場的詳細情形如何？
  • 根據給藥途徑，全球抗凝血劑市場的詳細情形如何？
  • 全球抗凝血劑市場按配銷通路分類是怎樣的？
  • 根據應用，全球抗凝血劑市場的詳細情形如何？
  • 全球抗凝血藥市場的重點區域有哪些？
  • 全球抗凝血劑市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球抗凝血劑市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依藥物類別

  • 新型口服抗凝血劑（NOAC）
    • 市場趨勢
    • 市場預測
  • 肝素和低分子肝素 (LMWH)
    • 市場趨勢
    • 市場預測
  • 維生素K拮抗劑
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依管理途徑

  • 口服抗凝血劑
    • 市場趨勢
    • 市場預測
  • 注射抗凝血劑
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥局
    • 市場趨勢
    • 市場預測
  • 網路商店
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按應用

  • 心房顫動和心臟病發作
    • 市場趨勢
    • 市場預測
  • 中風
    • 市場趨勢
    • 市場預測
  • 深部靜脈血栓 (DVT)
    • 市場趨勢
    • 市場預測
  • 肺栓塞（PE）
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Alexion Pharmaceuticals Inc
    • Aspen Holdings
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson Private Limited
    • Pfizer Inc.
    • Sanofi
Product Code: SR112024A4360

The global anticoagulants market size reached US$ 41.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 90.9 Billion by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032. The rising cases of thrombotic disorders, sedentary lifestyles, and the improving healthcare sector represent some of the key factors driving the market.

Anticoagulants are medicines that prevent the formation of blood clots and reduce the chances of developing severe conditions, such as strokes and heart attacks. They assist in treating existing blood clots that resist the flow of blood through vessels and prevent them from getting larger and reducing the risk of serious complications. They are available in different strengths and colors and as oral, such as tablets and capsules, and injectable variants. At present, direct oral anticoagulants (DOAc) are increasingly being prescribed on account of their ease of use and lack of need for routine monitoring.

Anticoagulants Market Trends:

The growing geriatric population and increasing prevalence of human immunodeficiency virus (HIV), lyme disease, obesity, hepatitis C, chronic inflammation, and cardiovascular disorders across the globe represent one of the key factors positively influencing the market across the globe. In addition, rising cases of thrombotic disorders, such as pulmonary embolism (PE), on account of sedentary lifestyles and hectic work schedules are inducing the growth of heart-related diseases worldwide. Moreover, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases are increasing the risk of blood clotting in different parts of the body, which, in turn, is catalyzing the demand for anticoagulants. Apart from this, increasing advancements in research and development (R&D) activities in drug discovery and the integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) to analyze large amounts of data, identify potential drug candidates and develop a new drug is fueling the market growth. In line with this, healthcare providers are focusing on personalizing anticoagulant therapy for individual patients based on their genetic and clinical data. AI assists in identifying the most effective dose and type of anticoagulant for the patient, which, in turn, reduces the risk of complications and improves outcomes. Furthermore, favorable initiatives by non-profitable organizations to promote awareness about cardiovascular health and the growing partnerships between governments of various countries and public health agencies to prevent heart disease and strokes are propelling the growth of the market worldwide. Other factors like the burgeoning healthcare sector and increasing affordability and accessibility of drugs are stimulating the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anticoagulants market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, route of administration, distribution channel and application.

Drug Class Insights:

Novel Oral Anticoagulants (NOACs)

Heparin and Low Molecular Weight Heparin (LMWH)

Vitamin K Antagonist

Others

The report has provided a detailed breakup and analysis of the anticoagulants market based on the drug class. This includes novel oral anticoagulants (NOACs), heparin and low molecular weight heparin (LMWH), vitamin K antagonist, and others. According to the report, novel oral anticoagulants (NOACs) represented the largest segment.

Route of Administration Insights:

Oral Anticoagulant

Injectable Anticoagulant

A detailed breakup and analysis of the anticoagulants market based on the route of administration has also been provided in the report. This includes oral anticoagulant and injectable anticoagulant. According to the report, oral anticoagulant accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Others

A detailed breakup and analysis of the anticoagulants market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, hospital pharmacies accounted for the largest market share.

Application Insights:

Atrial Fibrillation and Heart Attack

Stroke

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Others

A detailed breakup and analysis of the anticoagulants market based on the application has also been provided in the report. This includes atrial fibrillation and heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. According to the report, atrial fibrillation and heart attack accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for anticoagulants. Some of the factors driving the North America anticoagulants market included the increasing prevalence of thrombotic disorders, developed healthcare sector, ongoing research and development (R&D) activities in drug discovery etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global anticoagulants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sanofi, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global anticoagulants market in 2023?
  • 2. What is the expected growth rate of the global anticoagulants market during 2024-2032?
  • 3. What are the key factors driving the global anticoagulants market?
  • 4. What has been the impact of COVID-19 on the global anticoagulants market?
  • 5. What is the breakup of the global anticoagulants market based on the drug class?
  • 6. What is the breakup of the global anticoagulants market based on the route of administration?
  • 7. What is the breakup of the global anticoagulants market based on the distribution channel?
  • 8. What is the breakup of the global anticoagulants market based on the application?
  • 9. What are the key regions in the global anticoagulants market?
  • 10. Who are the key players/companies in the global anticoagulants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anticoagulants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Novel Oral Anticoagulants (NOACs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Heparin and Low Molecular Weight Heparin (LMWH)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Vitamin K Antagonist
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral Anticoagulant
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Injectable Anticoagulant
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Atrial Fibrillation and Heart Attack
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stroke
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Deep Vein Thrombosis (DVT)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pulmonary Embolism (PE)
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alexion Pharmaceuticals Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Aspen Holdings
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Boehringer Ingelheim International GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Daiichi Sankyo Company Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Dr. Reddy's Laboratories Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Johnson & Johnson Private Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
  • Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Anticoagulants Industry: SWOT Analysis
  • Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
  • Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Anticoagulants Market: Competitive Structure
  • Table 8: Global: Anticoagulants Market: Key Players